Antigen Information
General Information of This Antigen
| Antigen ID | TAR0XTCGM |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | B-cell receptor CD22 (CD22) |
|||||
| Gene Name | CD22 |
|||||
| Gene ID | ||||||
| Synonym | B-lymphocyte cell adhesion molecule;Sialic acid-binding Ig-like lectin 2;T-cell surface antigen Leu-14;CD_antigen=CD22 |
|||||
| Sequence |
MHLLGPWLLLLVLEYLAFSDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFH
NPEYNKNTSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLNDSGQLGLR MESKTEKWMERIHLNVSERPFPPHIQLPPEIQESQEVTLTCLLNFSCYGYPIQLQWLLEG VPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSNDTVQLNVKH TPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVT KDQSGKYCCQVSNDVGPGRSEEVFLQVQYAPEPSTVQILHSPAVEGSQVEFLCMSLANPL PTNYTWYHNGKEMQGRTEEKVHIPKILPWHAGTYSCVAENILGTGQRGPGAELDVQYPPK KVTTVIQNPMPIREGDTVTLSCNYNSSNPSVTRYEWKPHGAWEEPSLGVLKIQNVGWDNT TIACAACNSWCSWASPVALNVQYAPRDVRVRKIKPLSEIHSGNSVSLQCDFSSSHPKEVQ FFWEKNGRLLGKESQLNFDSISPEDAGSYSCWVNNSIGQTASKAWTLEVLYAPRRLRVSM SPGDQVMEGKSATLTCESDANPPVSHYTWFDWNNQSLPYHSQKLRLEPVKVQHSGAYWCQ GTNSVGKGRSPLSTLTVYYSPETIGRRVAVGLGSCLAILILAICGLKLQRRWKRTQSQQG LQENSSGQSFFVRNKKVRRAPLSEGPHSLGCYNPMMEDGISYTTLRFPEMNIPRTGDAES SEMQRPPPDCDDTVTYSALHKRQVGDYENVIPDFPEDEGIHYSELIQFGVGERPQAQENV DYVILKH Click to Show/Hide
|
|||||
| Family | LISCH7 family |
|||||
| Function |
Mediates B-cell B-cell interactions. May be involved in the localization of B-cells in lymphoid tissues. Binds sialylated glycoproteins; one of which is CD45. Preferentially binds to alpha-2,6- linked sialic acid. The sialic acid recognition site can be masked by cis interactions with sialic acids on the same cell surface. Upon ligand induced tyrosine phosphorylation in the immune response seems to be involved in regulation of B-cell antigen receptor signaling. Plays a role in positive regulation through interaction with Src family tyrosine kinases and may also act as an inhibitory receptor by recruiting cytoplasmic phosphatases via their SH2 domains that block signal transduction through dephosphorylation of signaling molecules.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
10F4v3 HC A118C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN106714844B ADC-102
[1]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
|
|
CN106714844B ADC-104
[1]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
10F4v3 LC A149C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN106714844B ADC-120
[1]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
|
|
CN106714844B ADC-122
[1]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Undisclosed |
|
|
CN106714844B ADC-124
[1]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
CN106714844B-ADC-124-linker |
|
|
CN106714844B ADC-126
[1]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
CN106714844B-ADC-126-linker |
|
|
CN107206101B ADC-2
[2]
|
Dolastatin10 |
Undisclosed |
MC-Sq-CIt-PAB |
|
|
CN107206101B ADC-2-2
[2]
|
Tubulysin M |
Undisclosed |
MC-Sq-CIt-PAB |
|
|
Anti- CD22 Disulfide-Tubulysin M
[2]
|
Tubulysin M |
Undisclosed |
Disulfide linker |
Anti-CD20 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TRPH-222
|
DM1 |
Microtubule (MT) |
HIPS-4AP |
Anti-CD22 10F4 Thiomab (LC:K149C)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD22-SN36248
[3]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2 |
Anti-CD22 Anti-ody (LC-K149C)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD22-SPDB-DM4
[4]
|
Mertansine DM4 |
Microtubule (MT) |
N-succinimidyl 4-(2-pyridyldithio) butanoate (SPDB) |
|
|
Anti-CD22-K149C-MBT-DM4
[4]
|
Mertansine DM4 |
Microtubule (MT) |
MBT |
|
|
Anti-CD22-K149C-MPEO-DM1
[4]
|
Mertansine DM1 |
Microtubule (MT) |
MPEO |
|
|
Anti-CD22-K149C-DM1
[4]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
Anti-CD22 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AZD4512
|
TOP1 inhibitor |
DNA topoisomerase 1 (TOP1) |
A cleavable linker |
Anti-CD22 mAb AbBJ
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AbBJ-ConjA
[5]
|
AbBJ-ConjA payload |
Undisclosed |
AbBJ-ConjA linker |
|
|
AbBJ-ConjB
[5]
|
AbBJ-ConjB payload |
Undisclosed |
AbBJ-ConjB linker |
|
|
AbBJ-ConjC
[5]
|
AbBJ-ConjC payload |
Undisclosed |
AbBJ-ConjC linker |
|
|
AbBJ-ConjD
[5]
|
AbBJ-ConjD payload |
Undisclosed |
AbBJ-ConjD linker |
|
|
AbBJ-ConjE
[5]
|
AbBJ-ConjE payload |
Undisclosed |
AbBJ-ConjE linker |
|
|
AbBJ-ConjF
[5]
|
AbBJ-ConjF payload |
Undisclosed |
AbBJ-ConjF linker |
|
|
AbBJ-ConjG
[5]
|
AbBJ-ConjG payload |
Undisclosed |
AbBJ-ConjG linker |
|
|
AbBJ-ConjH
[5]
|
AbBJ-ConjH payload |
Undisclosed |
AbBJ-ConjH linker |
Anti-CD22 mAb AbCJX
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AbCJX-ConjA
[5]
|
AbCJX-ConjA payload |
Undisclosed |
AbCJX-ConjA linker |
|
|
AbCJX-ConjB
[5]
|
AbCJX-ConjB payload |
Undisclosed |
AbCJX-ConjB linker |
|
|
AbCJX-ConjC
[5]
|
AbCJX-ConjC payload |
Undisclosed |
AbCJX-ConjC linker |
|
|
AbCJX-ConjD
[5]
|
AbCJX-ConjD payload |
Undisclosed |
AbCJX-ConjD linker |
|
|
AbCJX-ConjE
[5]
|
AbCJX-ConjE payload |
Undisclosed |
AbCJX-ConjE linker |
|
|
AbCJX-ConjF
[5]
|
AbCJX-ConjF payload |
Undisclosed |
AbCJX-ConjF linker |
|
|
AbCJX-ConjG
[5]
|
AbCJX-ConjG payload |
Undisclosed |
AbCJX-ConjG linker |
|
|
AbCJX-ConjH
[5]
|
AbCJX-ConjH payload |
Undisclosed |
AbCJX-ConjH linker |
Anti-CD22 mAb AbDJ
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AbDJ-ConjA
[5]
|
AbDJ-ConjA payload |
Undisclosed |
AbDJ-ConjA linker |
|
|
AbDJ-ConjB
[5]
|
AbDJ-ConjB payload |
Undisclosed |
AbDJ-ConjB linker |
|
|
AbDJ-ConjC
[5]
|
AbDJ-ConjC payload |
Undisclosed |
AbDJ-ConjC linker |
|
|
AbDJ-ConjD
[5]
|
AbDJ-ConjD payload |
Undisclosed |
AbDJ-ConjD linker |
|
|
AbDJ-ConjE
[5]
|
AbDJ-ConjE payload |
Undisclosed |
AbDJ-ConjE linker |
|
|
AbDJ-ConjF
[5]
|
AbDJ-ConjF payload |
Undisclosed |
AbDJ-ConjF linker |
|
|
AbDJ-ConjG
[5]
|
AbDJ-ConjG payload |
Undisclosed |
AbDJ-ConjG linker |
|
|
AbDJ-ConjH
[5]
|
AbDJ-ConjH payload |
Undisclosed |
AbDJ-ConjH linker |
Anti-CD22 mAb AbHJ
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AbHJ-ConjA
[5]
|
AbHJ-ConjA payload |
Undisclosed |
AbHJ-ConjA linker |
|
|
AbHJ-ConjB
[5]
|
AbHJ-ConjB payload |
Undisclosed |
AbHJ-ConjB linker |
|
|
AbHJ-ConjC
[5]
|
AbHJ-ConjC payload |
Undisclosed |
AbHJ-ConjC linker |
|
|
AbHJ-ConjD
[5]
|
AbHJ-ConjD payload |
Undisclosed |
AbHJ-ConjD linker |
|
|
AbHJ-ConjE
[5]
|
AbHJ-ConjE payload |
Undisclosed |
AbHJ-ConjE linker |
|
|
AbHJ-ConjF
[5]
|
AbHJ-ConjF payload |
Undisclosed |
AbHJ-ConjF linker |
|
|
AbHJ-ConjG
[5]
|
AbHJ-ConjG payload |
Undisclosed |
AbHJ-ConjG linker |
|
|
AbHJ-ConjH
[5]
|
AbHJ-ConjH payload |
Undisclosed |
AbHJ-ConjH linker |
Anti-CD22 mAb AbLJ
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
AbLJ-ConjA
[5]
|
AbLJ-ConjA payload |
Undisclosed |
AbLJ-ConjA linker |
|
|
AbLJ-ConjB
[5]
|
AbLJ-ConjB payload |
Undisclosed |
AbLJ-ConjB linker |
|
|
AbLJ-ConjC
[5]
|
AbLJ-ConjC payload |
Undisclosed |
AbLJ-ConjC linker |
|
|
AbLJ-ConjD
[5]
|
AbLJ-ConjD payload |
Undisclosed |
AbLJ-ConjD linker |
|
|
AbLJ-ConjE
[5]
|
AbLJ-ConjE payload |
Undisclosed |
AbLJ-ConjE linker |
|
|
AbLJ-ConjF
[5]
|
AbLJ-ConjF payload |
Undisclosed |
AbLJ-ConjF linker |
|
|
AbLJ-ConjG
[5]
|
AbLJ-ConjG payload |
Undisclosed |
AbLJ-ConjG linker |
|
|
AbLJ-ConjH
[5]
|
AbLJ-ConjH payload |
Undisclosed |
AbLJ-ConjH linker |
Anti-CD22 mAb HB22.7
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
HB22.7-SAP
[6]
|
Saporin |
Microtubule (MT) |
Undisclosed |
Anti-CD22 mAb xCD22
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2013055987A1 xCD22-103
[7]
|
SG2000 |
Human Deoxyribonucleic acid (hDNA) |
WO2013055987A1_xCD22-103 linker |
Anti-CD22-HC-A140C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Alpha-CD22-HC-A140C-10
[8]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mc-peptidomimetic based linker 10 |
|
|
Alpha-CD22-HC-A140C-11
[8]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mc-PEG2 |
Anti-CD22-LC-K149C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
ACD22-LC-K149C-10
[9]
|
PA-seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mc-cBu-Cit |
|
|
Alpha-CD22-LC-K149C-10
[8]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mc-peptidomimetic based linker 10 |
|
|
Alpha-CD22-LC-K149C-11
[8]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2 |
|
|
Alpha-CD22-LC-K149C-12
[8]
|
Seco-CBI-dimer 12 |
Human Deoxyribonucleic acid (hDNA) |
Mc-peptidomimetic based linker 12 |
Anti-CD22-LC-V205C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Alpha-CD22-LC-V205C-10
[8]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mc-peptidomimetic based linker 10 |
CD22 Nanobody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CD22 Nanobody DM1
[10]
|
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4- (N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
CN105828840B_ADC-101 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-101
[11]
|
CN105828840B_ADC-101 payload |
Undisclosed |
CN105828840B_ADC-101 linker |
CN105828840B_ADC-104 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-104
[11]
|
CN105828840B_ADC-104 payload |
Undisclosed |
CN105828840B_ADC-104 linker |
CN105828840B_ADC-108 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-108
[11]
|
CN105828840B_ADC-108 payload |
Undisclosed |
CN105828840B_ADC-108 linker |
CN105828840B_ADC-110 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-110
[11]
|
CN105828840B_ADC-110 payload |
Undisclosed |
CN105828840B_ADC-110 linker |
CN105828840B_ADC-111 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-111
[11]
|
CN105828840B_ADC-111 payload |
Undisclosed |
CN105828840B_ADC-111 linker |
CN105828840B_ADC-115 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-115
[11]
|
CN105828840B_ADC-115 payload |
Undisclosed |
CN105828840B_ADC-115 linker |
CN105828840B_ADC-116 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-116
[11]
|
CN105828840B_ADC-116 payload |
Undisclosed |
CN105828840B_ADC-116 linker |
CN105828840B_ADC-120 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-120
[11]
|
CN105828840B_ADC-120 payload |
Undisclosed |
CN105828840B_ADC-120 linker |
CN105828840B_ADC-122 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-122
[11]
|
CN105828840B_ADC-122 payload |
Undisclosed |
CN105828840B_ADC-122 linker |
CN105828840B_ADC-124 antibody
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CN105828840B ADC-124
[11]
|
CN105828840B_ADC-124 payload |
Undisclosed |
CN105828840B_ADC-124 linker |
Epratuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Epratuzumab-cys-tesirine
|
SG3199 (SC-DR002) |
Human deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
|
|
BAY-1862864
|
227Th |
Undisclosed |
Undisclosed |
|
|
Emab-CL2E-SN38
[12]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2E |
|
|
RNAse monoclonal antibody-LL2-I-131-conjugate
[13]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
HLL2-PBD
[14]
|
SG3199 |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG8-Val-Ala-PABC |
|
|
Epratuzumab-CL2E-SN-38
[15]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2E |
|
|
Epratuzumab-SN-38
[15]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
|
|
Epratuzumab-SN38
[16]
|
Active metabolite of irinotecan SN38 |
DNA topoisomerase 1 (TOP1) |
CL2A |
G5/44
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
CMC-544
|
Undisclosed |
Undisclosed |
Undisclosed |
Inotuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Inotuzumab ozogamicin
[17]
|
N-acetyl-gamma-calicheamicin |
Human deoxyribonucleic acid (hDNA) |
AcButDMH |
|
|
Inotuzumab-ADC-24-1
[18]
|
Inotuzumab-ADC-24-1 payload |
Undisclosed |
Inotuzumab-ADC-24-1 linker |
|
|
Inotuzumab-ADC-24-2
[18]
|
Inotuzumab-ADC-24-2 payload |
Undisclosed |
Inotuzumab-ADC-24-2 linker |
|
|
Inotuzumab-ADC-24-3
[18]
|
Inotuzumab-ADC-24-3 payload |
Undisclosed |
Inotuzumab-ADC-24-3 linker |
|
|
Inotuzumab-ADC-24-4
[18]
|
Inotuzumab-ADC-24-4 payload |
Undisclosed |
Inotuzumab-ADC-24-4 linker |
|
|
Inotuzumab-ADC-24-5
[18]
|
Inotuzumab-ADC-24-5 payload |
Undisclosed |
Inotuzumab-ADC-24-5 linker |
|
|
Inotuzumab-ADC-24-6
[18]
|
Inotuzumab-ADC-24-6 payload |
Undisclosed |
Inotuzumab-ADC-24-6 linker |
|
|
Inotuzumab-ADC-24-7
[18]
|
Inotuzumab-ADC-24-7 payload |
Undisclosed |
Inotuzumab-ADC-24-7 linker |
|
|
Inotuzumab-ADC-24-8
[18]
|
Inotuzumab-ADC-24-8 payload |
Undisclosed |
Inotuzumab-ADC-24-8 linker |
|
|
Inotuzumab-ADC-24-9
[18]
|
Inotuzumab-ADC-24-9 payload |
Undisclosed |
Inotuzumab-ADC-24-9 linker |
|
|
Inotuzumab-ADC-24-10
[18]
|
Inotuzumab-ADC-24-10 payload |
Undisclosed |
Inotuzumab-ADC-24-10 linker |
|
|
Inotuzumab-ADC-24-11
[18]
|
Inotuzumab-ADC-24-11 payload |
Undisclosed |
Inotuzumab-ADC-24-11 linker |
|
|
Inotuzumab-ADC-24-12
[18]
|
Inotuzumab-ADC-24-12 payload |
Undisclosed |
Inotuzumab-ADC-24-12 linker |
|
|
Inotuzumab-ADC-24-13
[18]
|
Inotuzumab-ADC-24-13 payload |
Undisclosed |
Inotuzumab-ADC-24-13 linker |
|
|
JP7623413B2 ExampleADC62
[19]
|
Undisclosed |
Undisclosed |
Undisclosed |
Mozistobart
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TAC-001
|
Differentiated TLR-9 agonist (T-CpG) |
Undisclosed |
Undisclosed |
Pinatuzumab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Pinatuzumab vedotin
|
MMAE |
Microtubule (MT) |
Mc-Val-Cit-PABC |
|
|
Anti-CD22- (LC:K149C)-SN36248
[3]
|
seco-CBI-dimer |
Human Deoxyribonucleic acid (hDNA) |
Mal-PEG2 |
|
|
Anti-CD22-NMS249
[20]
|
PNU-159682 |
DNA topoisomerase 2-alpha (TOP2A) |
Mc-Val-Cit-PAB-DEA |
|
|
Pinatuzumab-ADC-24-1
[18]
|
Pinatuzumab-ADC-24-1 payload |
Undisclosed |
Pinatuzumab-ADC-24-1 linker |
|
|
Pinatuzumab-ADC-24-2
[18]
|
Pinatuzumab-ADC-24-2 payload |
Undisclosed |
Pinatuzumab-ADC-24-2 linker |
|
|
Pinatuzumab-ADC-24-3
[18]
|
Pinatuzumab-ADC-24-3 payload |
Undisclosed |
Pinatuzumab-ADC-24-3 linker |
|
|
Pinatuzumab-ADC-24-4
[18]
|
Pinatuzumab-ADC-24-4 payload |
Undisclosed |
Pinatuzumab-ADC-24-4 linker |
|
|
Pinatuzumab-ADC-24-5
[18]
|
Pinatuzumab-ADC-24-5 payload |
Undisclosed |
Pinatuzumab-ADC-24-5 linker |
|
|
Pinatuzumab-ADC-24-6
[18]
|
Pinatuzumab-ADC-24-6 payload |
Undisclosed |
Pinatuzumab-ADC-24-6 linker |
|
|
Pinatuzumab-ADC-24-7
[18]
|
Pinatuzumab-ADC-24-7 payload |
Undisclosed |
Pinatuzumab-ADC-24-7 linker |
|
|
Pinatuzumab-ADC-24-8
[18]
|
Pinatuzumab-ADC-24-8 payload |
Undisclosed |
Pinatuzumab-ADC-24-8 linker |
|
|
Pinatuzumab-ADC-24-9
[18]
|
Pinatuzumab-ADC-24-9 payload |
Undisclosed |
Pinatuzumab-ADC-24-9 linker |
|
|
Pinatuzumab-ADC-24-10
[18]
|
Pinatuzumab-ADC-24-10 payload |
Undisclosed |
Pinatuzumab-ADC-24-10 linker |
|
|
Pinatuzumab-ADC-24-11
[18]
|
Pinatuzumab-ADC-24-11 payload |
Undisclosed |
Pinatuzumab-ADC-24-11 linker |
|
|
Pinatuzumab-ADC-24-12
[18]
|
Pinatuzumab-ADC-24-12 payload |
Undisclosed |
Pinatuzumab-ADC-24-12 linker |
|
|
Pinatuzumab-ADC-24-13
[18]
|
Pinatuzumab-ADC-24-13 payload |
Undisclosed |
Pinatuzumab-ADC-24-13 linker |
RFB4
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
RFB4-SMPT-dgA
|
Deglycosylated ricin A-chain (dgA) |
Undisclosed |
Succynimidyloxycarbonyl-alpha-methyl-alpha- (2-pyridyl-dithio) toluene (SMPT) |
Thio Anti-CD22 10F4v3 LC V205C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017214024A1 ADC-101
[21]
|
WO2017214024A1_ADC-101 payload |
Undisclosed |
WO2017214024A1_ADC-101 linker |
Thio hu Anti-CD22 10F43 HC L177C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017059289A1 ADC-116
[22]
|
WO2017059289A1_ADC-116 payload |
Undisclosed |
WO2017059289A1_ADC-116 linker |
Thio hu Anti-CD22 10F4v3
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017059289A1 ADC-202
[22]
|
WO2017059289A1_ADC-202 payload |
Undisclosed |
WO2017059289A1_ADC-202 linker |
Thio hu Anti-CD22 10F4v3 HC A118C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2014159981A2 ADC-115
[23]
|
WO2014159981A2_ADC-115 payload |
Undisclosed |
WO2014159981A2_ADC-115 linker |
|
|
WO2014159981A2 ADC-125
[23]
|
WO2014159981A2_ADC-125 payload |
Undisclosed |
WO2014159981A2_ADC-125 linker |
|
|
WO2014159981A2 ADC-212
[23]
|
WO2014159981A2_ADC-212 payload |
Undisclosed |
WO2014159981A2_ADC-212 linker |
|
|
WO2014159981A2 ADC-135
[23]
|
WO2014159981A2_ADC-135 payload |
Undisclosed |
WO2014159981A2_ADC-135 linker |
|
|
WO2014159981A2 ADC-CD22-41
[23]
|
WO2014159981A2_ADC-CD22-41 payload |
Undisclosed |
WO2014159981A2_ADC-CD22-41 linker |
|
|
WO2014159981A2 ADC-CD22-44
[23]
|
WO2014159981A2_ADC-CD22-44 payload |
Undisclosed |
WO2014159981A2_ADC-CD22-44 linker |
|
|
WO2014159981A2 ADC-CD22-48
[23]
|
WO2014159981A2_ADC-CD22-48 payload |
Undisclosed |
WO2014159981A2_ADC-CD22-48 linker |
|
|
WO2014159981A2 ADC-CD22-22
[23]
|
WO2014159981A2_ADC-CD22-22 payload |
Undisclosed |
WO2014159981A2_ADC-CD22-22 linker |
Thio hu Anti-CD22 10F4v3 HC A140C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017214024A1 ADC-105
[21]
|
WO2017214024A1_ADC-105 payload |
Undisclosed |
WO2017214024A1_ADC-105 linker |
Thio hu Anti-CD22 10F4v3 HC Y376C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017059289A1 ADC-118
[22]
|
WO2017059289A1_ADC-118 payload |
Undisclosed |
WO2017059289A1_ADC-118 linker |
Thio hu Anti-CD22 10F4v3 LC K149C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017059289A1 ADC-103
[22]
|
WO2017059289A1_ADC-103 payload |
Undisclosed |
WO2017059289A1_ADC-103 linker |
|
|
WO2017059289A1 ADC-105
[22]
|
WO2017059289A1_ADC-105 payload |
Undisclosed |
WO2017059289A1_ADC-105 linker |
|
|
WO2017059289A1 ADC-107
[22]
|
WO2017059289A1_ADC-107 payload |
Undisclosed |
WO2017059289A1_ADC-107 linker |
|
|
WO2017059289A1 ADC-110
[22]
|
WO2017059289A1_ADC-110 payload |
Undisclosed |
WO2017059289A1_ADC-110 linker |
|
|
WO2017059289A1 ADC-204
[22]
|
WO2017059289A1_ADC-204 payload |
Undisclosed |
WO2017059289A1_ADC-204 linker |
|
|
WO2017059289A1 ADC-206
[22]
|
WO2017059289A1_ADC-206 payload |
Undisclosed |
WO2017059289A1_ADC-206 linker |
|
|
WO2017059289A1 ADC-207
[22]
|
WO2017059289A1_ADC-207 payload |
Undisclosed |
WO2017059289A1_ADC-207 linker |
|
|
WO2017214024A1 ADC-104
[21]
|
WO2017214024A1_ADC-104 payload |
Undisclosed |
WO2017214024A1_ADC-104 linker |
|
|
WO2017214024A1 ADC-108
[21]
|
WO2017214024A1_ADC-108 payload |
Undisclosed |
WO2017214024A1_ADC-108 linker |
|
|
WO2017214024A1 ADC-110
[21]
|
WO2017214024A1_ADC-110 payload |
Undisclosed |
WO2017214024A1_ADC-110 linker |
Thio hu Anti-CD22 10F4v3 LC K149C HC L177C
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2017059289A1 ADC-111
[22]
|
WO2017059289A1_ADC-111 payload |
Undisclosed |
WO2017059289A1_ADC-111 linker |
|
|
WO2017059289A1 ADC-112
[22]
|
WO2017059289A1_ADC-112 payload |
Undisclosed |
WO2017059289A1_ADC-112 linker |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-CD22 antibody drug-conjugate (Medarex/BMS)
[24]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Anti-CD22 antibody-drug conjugate (Ambrx)
[25]
|
Undisclosed |
Undisclosed |
Undisclosed |
References
